Sign up to save your podcasts
Or
Share Dr Kultar Garcha | Episode 35
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Dr Kultar Garcha | Episode 35
In this episode of The Only Way is Ethics, I’m joined by Dr Kultar Garcha, Chief Medical Officer at Flow Neuroscience, NHS GP and clinical leader with a strong background in digital health, quality improvement and patient safety.
Kultar brings a fascinating perspective to the conversation, combining frontline clinical experience with his role in a company developing regulated neuromodulation technology for depression. Flow Neuroscience is working in one of the most interesting areas of digital therapeutics, using transcranial direct current stimulation as part of a home-based treatment model for mental health.
During the episode, we explore Kultar’s journey from general practice into digital health leadership, the role of the Chief Medical Officer in a regulated health technology company, and how neuromodulation should be understood as a clinical intervention rather than consumer wellness technology.
We also discuss the importance of evidence, responsible communication of clinical claims, and what healthcare organisations should consider when adopting emerging technologies. As treatment increasingly moves into the home, we consider how clinical risk management needs to evolve, including patient selection, intended use, contraindications, escalation, monitoring and shared responsibility between manufacturers, clinicians, patients and adopting organisations.
Given Kultar has recently completed the DPM Digital Health Clinical Safety Officer Practitioner course, we also explore how clinical risk management applies to AI, digital therapeutics and connected health technologies, and what responsible innovation means in practice.
This is a clinically grounded conversation about neuromodulation, digital mental health, AI, clinical safety and the future of responsible digital health innovation.
This podcast is for informational purposes only and should not be considered legal health advice.We are not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.This podcast is not intended to replace professional medical advice.The views expressed in this podcast may not be those of the host or the management.
View all episodes
By DPM Digital HealthIn this episode of The Only Way is Ethics, I’m joined by Dr Kultar Garcha, Chief Medical Officer at Flow Neuroscience, NHS GP and clinical leader with a strong background in digital health, quality improvement and patient safety.
Kultar brings a fascinating perspective to the conversation, combining frontline clinical experience with his role in a company developing regulated neuromodulation technology for depression. Flow Neuroscience is working in one of the most interesting areas of digital therapeutics, using transcranial direct current stimulation as part of a home-based treatment model for mental health.
During the episode, we explore Kultar’s journey from general practice into digital health leadership, the role of the Chief Medical Officer in a regulated health technology company, and how neuromodulation should be understood as a clinical intervention rather than consumer wellness technology.
We also discuss the importance of evidence, responsible communication of clinical claims, and what healthcare organisations should consider when adopting emerging technologies. As treatment increasingly moves into the home, we consider how clinical risk management needs to evolve, including patient selection, intended use, contraindications, escalation, monitoring and shared responsibility between manufacturers, clinicians, patients and adopting organisations.
Given Kultar has recently completed the DPM Digital Health Clinical Safety Officer Practitioner course, we also explore how clinical risk management applies to AI, digital therapeutics and connected health technologies, and what responsible innovation means in practice.
This is a clinically grounded conversation about neuromodulation, digital mental health, AI, clinical safety and the future of responsible digital health innovation.
This podcast is for informational purposes only and should not be considered legal health advice.We are not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.This podcast is not intended to replace professional medical advice.The views expressed in this podcast may not be those of the host or the management.